BlackRock’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.2M Sell
4,743,076
-186,163
-4% -$628K ﹤0.01% 3205
2025
Q4
$13.9M Sell
4,929,239
-48,319
-1% -$249K ﹤0.01% 3291
2025
Q3
$34.6M Buy
4,977,558
+372
+0% +$2.62K ﹤0.01% 2741
2025
Q2
$29.5M Buy
4,977,186
+17,014
+0.3% +$97.9K ﹤0.01% 2798
2025
Q1
$31.7M Sell
4,960,172
-41,033
-0.8% -$396K ﹤0.01% 2647
2024
Q4
$59.4M Buy
5,001,205
+336,880
+7% +$5.74M ﹤0.01% 2349
2024
Q3
$129M Buy
4,664,325
+171,929
+4% +$4.3M ﹤0.01% 1936
2024
Q2
$107M Buy
4,492,396
+429,479
+11% +$10.1M ﹤0.01% 1980
2024
Q1
$71.5M Buy
4,062,917
+7,931
+0.2% +$117K ﹤0.01% 2249
2023
Q4
$64M Buy
4,054,986
+181,279
+5% +$1.87M ﹤0.01% 2332
2023
Q3
$33.3M Buy
3,873,707
+21,296
+0.6% +$151K ﹤0.01% 2641
2023
Q2
$30.4M Buy
3,852,411
+364,579
+10% +$2.54M ﹤0.01% 2782
2023
Q1
$26M Buy
3,487,832
+1,086,394
+45% +$10.8M ﹤0.01% 2837
2022
Q4
$28.3M Buy
2,401,438
+482,454
+25% +$5.51M ﹤0.01% 2841
2022
Q3
$17.7M Buy
1,918,984
+142,611
+8% +$1.73M ﹤0.01% 3103
2022
Q2
$17.6M Buy
1,776,373
+244,791
+16% +$4.94M ﹤0.01% 3149
2022
Q1
$52.8M Sell
1,531,582
-21,008
-1% -$682K ﹤0.01% 2550
2021
Q4
$77.3M Buy
1,552,590
+144,291
+10% +$7.6M ﹤0.01% 2378
2021
Q3
$64.8M Sell
1,408,299
-166,273
-11% -$6.59M ﹤0.01% 2495
2021
Q2
$47.1M Sell
1,574,572
-282,176
-15% -$5.76M ﹤0.01% 2739
2021
Q1
$37.8M Buy
1,856,748
+55,774
+3% +$1.18M ﹤0.01% 2805
2020
Q4
$30.1M Buy
1,800,974
+347,880
+24% +$4.57M ﹤0.01% 2791
2020
Q3
$15.9M Buy
1,453,094
+61,031
+4% +$483K ﹤0.01% 2992
2020
Q2
$9.16M Buy
1,392,063
+892,970
+179% +$5.73M ﹤0.01% 3230
2020
Q1
$3.06M Buy
499,093
+9,740
+2% +$79.1K ﹤0.01% 3528
2019
Q4
$3.8M Sell
489,353
-3,930
-0.8% -$27.1K ﹤0.01% 3579
2019
Q3
$2.92M Sell
493,283
-9,425
-2% -$59.9K ﹤0.01% 3638
2019
Q2
$3.58M Buy
502,708
+105,803
+27% +$480K ﹤0.01% 3612
2019
Q1
$1.01M Sell
396,905
-17,397
-4% -$51.7K ﹤0.01% 3909
2018
Q4
$883K Buy
414,302
+27,783
+7% +$94.1K ﹤0.01% 3930
2018
Q3
$1.77M Sell
386,519
-4,633
-1% -$22.6K ﹤0.01% 3818
2018
Q2
$1.92M Buy
391,152
+6,345
+2% +$30.1K ﹤0.01% 3757
2018
Q1
$1.64M Sell
384,807
-38,142
-9% -$180K ﹤0.01% 3731
2017
Q4
$2.06M Sell
422,949
-33,774
-7% -$157K ﹤0.01% 3688
2017
Q3
$1.99M Sell
456,723
-1,583
-0.3% -$6.92K ﹤0.01% 3706
2017
Q2
$2.04M Sell
458,306
-23,061
-5% -$97.4K ﹤0.01% 3680
2017
Q1
$2M Buy
481,367
+479,719
+29,109% +$2.04M ﹤0.01% 3653
2016
Q4
$7K Sell
1,648
-707
-30% -$3.44K ﹤0.01% 3459
2016
Q3
$14K Hold
2,355
﹤0.01% 3346
2016
Q2
$12K Buy
+2,355
New +$10.3K ﹤0.01% 3376

Other funds holding ASPN

BlackRock's ASPN Position: Q1 2026 in Review

BlackRock reduced its Aspen Aerogels (ASPN) stake by 3.8% in Q1 2026, selling an estimated $628K and leaving 4,743,076 shares worth $16.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3205.

BlackRock first reported a position in ASPN in Q2 2016 and has held it in 40 quarters since. The position peaked at $129M in Q3 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • BlackRock held 4,743,076 shares of Aspen Aerogels worth $16.2M as of Q1 2026.
  • BlackRock sold 186,163 Aspen Aerogels shares in Q1 2026, an estimated $628K.
  • Aspen Aerogels made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3205 holding.
  • BlackRock first reported a position in Aspen Aerogels in Q2 2016 and has held it in 40 quarters since.
  • BlackRock's Aspen Aerogels position peaked at $129M in Q3 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.